Basal cell carcinoma (BCC) is a common skin cancer originating from basal cells in the epidermis. It is primarily caused by prolonged exposure to ultraviolet (UV) radiation. Clinically significant due to its potential for local invasion and destruction of surrounding tissues, BCC rarely metastasizes. Accurate coding with ICD-10 Code C44.711 ensures proper diagnosis, documentation, and billing, facilitating effective public health reporting and resource allocation.
ICD-10 Code C44.711 specifically denotes basal cell carcinoma of the skin located on the unspecified lower limb, including the hip. This code is utilized when documenting cases of BCC that do not have a specified location within the lower limb. It is essential for accurate clinical documentation and billing, particularly when assessing skin lesions and planning treatment.
Basal cell carcinoma is primarily caused by UV radiation exposure, leading to mutations in skin cells. It typically presents as a pearly or waxy bump and may ulcerate over time. Early detection and treatment are crucial to prevent local tissue damage and complications.
ICD-10 Code C44.711 is integral in SOAP notes for documenting the patient's symptoms, assessment findings, and treatment plans. It aids in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
In SOAP notes, ICD-10 Code C44.711 connects subjective patient reports and objective clinical findings to a formal diagnosis of basal cell carcinoma. This code supports continuity of care, facilitates billing processes, and meets EHR documentation standards.
Timely intervention for basal cell carcinoma is essential to prevent progression. Treatment options vary based on tumor size and location.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C44.711 is crucial for accurate billing in hospital and outpatient settings, particularly for dermatological care.
CPT Code | Description |
---|---|
11400 | Excision, benign skin lesion, face, ears, scalp, neck; excised diameter up to 4.0 cm. |
12001 | Simple repair of superficial wounds, face, ears, scalp, neck; 2.5 cm or less. |
17000 | Destruction of premalignant skin lesions, first lesion. |
Common Questions About Using ICD-10 Code C44.711 for Basal cell carcinoma skin/ unsp lower limb, including hip
What are the common symptoms of basal cell carcinoma?
Common symptoms include a pearly or waxy bump, flat scar-like lesions, or ulcers that do not heal. Patients may also report tenderness or itching in the affected area.
How is basal cell carcinoma treated?
Treatment options include surgical excision, cryotherapy, topical chemotherapy, and Mohs micrographic surgery, depending on the size and location of the tumor.
Is basal cell carcinoma contagious?
No, basal cell carcinoma is not contagious. It is primarily caused by UV exposure and does not spread from person to person.
How often should patients with a history of basal cell carcinoma be monitored?
Patients with a history of basal cell carcinoma should have regular skin examinations, typically every 6 to 12 months, to monitor for new lesions or recurrences.
Clinical Notes
SOAP notes
DAP notes
AI medical notes